US Drug Recall Register
Class II · Moderate risk Ongoing Initiated Sep 24, 2024 (2 years ago)

Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Delivery System: The dip tube is clogged causing the spray not to work.

What was recalled

Ryaltris (olopatadine hydrochloride and mometasone fluorate) Nasal Spray, 665 mcg/25 mcg per spray, 240 Metered Sprays/bottle, 29 g net fill weight, Distr. by Hikma Specialty USA Inc., Columbus, OH 43328, hikma, Glenmark Specialty SA. NDC 59467-700-27.

Recalling firm
Glenmark Pharmaceuticals Inc., USA
NDC code
59467-700-27
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0006-2025

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all